Bosentan hydrate

Bosentan Hydrate is a dual endothelin receptor antagonist (ETA/ETB) used for the management of pulmonary arterial hypertension. Simson Pharma's Bosentan Hydrate reference standard and impurities support stability-indicating method development for this specialised cardiopulmonary therapy.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bosentan hydrate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Bosentan Monohydrate
O-Deshydroxyethyl Bosentan
Bosentan USP Related Compound A
Bosentan Chlorosulfonamide Cesium Salt
Bosentan USP Related Compound D
Bosentan Dimer Impurity
Bosentan USP Related Compound E
Bosentan Monohydrate Ethyl Ester Impurity
N,N'-[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-4,6-diyl]bis[4-(1,1-dimethylethyl)benzenesulfonamide]
O-Desmethyl Bosentan
Bosentan Impurity 9
Bosentan hydroxyethoxy Ethyl
4-(tert-butyl)-N-((tertbutyl)phenyl)sulfonyl)benzenesulfonamide
2-Methyl-2-phenylpropanoic acid
Bosentan Impurity 5
Bosentan Impurity 3
Bosentan Impurity 4
4-tert-butylbenzenesulfonic acid
Bosentan Related Compound B
Bosentan Related Compound 4
4-tert-butyl-N-[6-ethoxy-5-(2-methoxyphenoxy)-[2,2`-bipyrimidin]-4-yl]benzene-1-sulfonamide
Bosentan Impurity 6
Bosentan Chloro Impurity
Bosentan Impurity 1
Bosentan Impurity 2
Bosentan Impurity 7
Bosentan Impurity 8
Bosentan Impurity 10
Bosentan Impurity 11
Bosentan Impurity 12
Bosentan Impurity 13
Bosentan Impurity 14
Bosentan Impurity 15
Bosentan Impurity 16
Bosentan Impurity 17

Isotope Labelled Compounds

Bosentan-D4
Bosentan 13C6